Watson's World
By Jesse Reynolds
| 10. 24. 2007
Nobel Prize season has come to an awkward end. Once a day during last week, we heard announcements of the winners in the six fields, including a high-profile award to Al Gore. The recipients will forever be honored to include the word "laureate" in their biographies.
But a few days later, the most prominent Nobel scientist winning scientist deeply marred his reputation. James Watson, who in 1962 won the prize for his elucidation of DNA's structure, unequivocally stated in an interview with the United Kingdom's Sunday Times that black people are less intelligent than whites. Speaking on development programs in Africa, Watson lamented that "all our social policies are based on the fact that their intelligence is the same as ours - whereas all the testing says not really… [P]eople who have to deal with black employees find [equality] is not true."
It may be tempting to dismiss this stunning utterance as the sloppy, irrelevant ramblings of a once-great scientist who is well past his prime. But Watson is a remarkably influential figure who has consistently reduced behavior to biology...
Related Articles
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Sophie Ryall , BioNews | 08.03.2026
A fertility doctor is being sued for using his own sperm during artificial insemination procedures without the patient's knowledge or consent.
Dr Dennis Lutz used his own sperm repeatedly when treating patient Jean Ann Nelson at the Medical Arts Clinic...